Abstract
The ataxia telangiectasia mutated and Rad3-related (ATR)-CHK1 pathway is the major signalling cascade activated in response to DNA replication stress. This pathway is associated with the core of the DNA replication machinery comprising CDC45, the replicative MCM2-7 hexamer, GINS (altogether forming the CMG complex), primase–polymerase (POLε, -α, and -δ) complex, and additional fork protection factors such as AND-1, CLASPIN (CLSPN), and TIMELESS/TIPIN. In this study, we report that functional protein kinase CK2α is critical for preserving replisome integrity and for mounting S-phase checkpoint signalling. We find that CDC45, CLSPN and MCM7 are novel CK2α interacting partners and these interactions are particularly important for maintenance of stable MCM7–CDC45, ATRIP–ATR–MCM7, and ATR–CLSPN protein complexes. Consistently, cells depleted of CK2α and treated with hydroxyurea display compromised replisome integrity, reduced chromatin binding of checkpoint mediator CLSPN, attenuated ATR-mediated S-phase checkpoint and delayed recovery of stalled forks. In further support of this, differential gene expression analysis by RNA-sequencing revealed that down-regulation of CK2α accompanies global shutdown of genes that are implicated in the S-phase checkpoint. These findings add to our understanding of the molecular mechanisms involved in DNA replication by showing that the protein kinase CK2α is essential for maintaining the stability of the replisome machinery and for optimizing ATR-CHK1 signalling activation upon replication stress.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
DNA replication occurs in the S-phase; however, the assembly of pre-replicative complexes (pre-RCs) begins several hours earlier in the cells in preparation to this event. The multi-subunit origin recognition complex (ORC) bound to chromatin primes this process by facilitating the recruitment of Cdc6, Cdt1 and the minichromosome maintenance (MCM2-7) proteins to distinct replication origin sites on the DNA. It follows recruitment of additional factors including cell division cycle 45 (CDC45) and the go-ichi-ni-san (GINS) complex to form the so-called CMG complex that represents the core of helicase activity [1, 2]. Several lines of evidence indicated that MCM2-7 are replicative helicases, which in combination with the aforementioned essential replisome factors (i.e. CDC45 and GINS) unwind segments of the DNA double helix during the replication process [1, 2]. Initiation of DNA replication during S-phase also requires the phosphorylation of components of the pre-RC catalysed by cyclin E-CDK2 and Cdc7-Dbf4 and subsequent association of three DNA polymerases (i.e. Pol α, Pol ε and Pol δ) at origin of replication. At this point replication can be started [3, 4].
During DNA synthesis, the unwinding of DNA leaves a single strand vulnerable. Eukaryotic cells are equipped with surveillance mechanisms coupled to the replisome that detect errors or problems occurring during this process and arrest the cell cycle allowing time for DNA repair to ensure the stability of the genome. In the eventuality of DNA damage and, specifically, DNA replication stress, long stretches of single-stranded DNA (ssDNA) coated by replisome protein A (RPA) are formed and a checkpoint signalling cascade is activated.
The ataxia telangiectasia mutated and Rad3-related kinase (ATR) and its obligate binding partner ATRIP, are recruited to RPA-coated ssDNA stretches and this is followed by binding of 9–1–1 (Rad9–Hus1–Rad1) heterotrimeric clamp and its clamp-loader Rad17 to sites of stalled replication fork [5, 6]. The presence of 9–1–1 on chromatin facilitates the interaction of ATR–ATRIP and a group of checkpoint mediators including TopBP1 and Mrc1/CLSPN [4].Compelling evidence has indicated that CLSPN is associated with chromatin and interacts with the checkpoint kinase CHK1 in response to stalled replication fork promoting checkpoint signalling at the replisome [7,8,9,10]. Here, one important role of ATR in response to replication block is the phosphorylation of several replication proteins including CLSPN, MCM2-7, H2AX and CHK1 [11]. Phosphorylation of the effector kinase CHK1 at S345 and S317 by ATR enhances its kinase activity, resulting in dissociation from chromatin, phosphorylation of CDC25A-C phosphatases, which prevent the progression of the cell cycle [11,12,13]. Efficient phosphorylation of CHK1 in response to replication block also requires the intervention of other factors, notably, MCM7, Rad17, TopBP1, the MRN complex and CLSPN. Similar to yeast, vertebrate ATR primarily utilizes adaptor CLSPN to mediate the activation of CHK1 by tethering it in proximity to ATR allowing for extensive phosphorylation and full activation of the effector kinase [14, 15].
CK2 is an evolutionarily conserved serine-threonine protein kinase that has been linked to the regulation of various intracellular processes including DNA transcription, cell cycle transition, protein translation, cell survival and cell death [16,17,18,19,20]. CK2 has been traditionally described as a constitutively active heterotetrametric enzyme composed of two catalytic subunits α and/or α’ and two regulatory β-subunits. However, accumulating evidence has indicated that these proteins may exist as individual isoforms in cells [21, 22]. Data based on gene targeting by homologous recombination has strengthen the notion that the three CK2 subunits might be also functionally specialized in vivo. For instance, although the CK2α and CK2α’ genes share approximately 90% sequence identity, genetic studies have shown that the phenotypic response to gene disruption is markedly different. Mice lacking CK2α die in mid gestation and show abnormality in a number of tissues and organs including the neural tube and heart [23] whereas homozygous deletion of CK2α' results in viable offspring although the male mice are infertile and affected by globozoospermia [24]. CK2 has been shown to positively regulate cell cycle progression in cancer cells by interacting and/or phosphorylating a number of proteins including p53, PLK1, CHK1, Wee1, MDC1, DNA-PK, and 53BP1 [25,26,27,28,29,30,31,32,33], but the function of CK2 in non-cancerous cells has not been explored to the same extent.
We previously showed that down-regulation of CK2α in normal myoblast cells derived from rat heart tissue (hereafter referred to as H9c2-CK2α-44) results in decreased cell proliferation, delayed G1/S-phase transition and defective response to mild DNA replication stress [22], which if unaddressed, could have serious implications for the genome stability of mammalian cells. Decreased proliferation of cardiomyocytes was also shown in vivo with CK2α-knockout mice strongly supporting the notion that this process is regulated by this protein kinase [22].
The aim of the present study was to shed light on the underlying molecular mechanisms by which CK2α regulates the DNA replication machinery and replication checkpoint activation. Our results show an interplay between CK2α and the replisome and that this protein kinase plays a critical role in the activation of the ATR-CHK1-mediated signalling pathway by ensuring stable association of replication factors on chromatin in response to a stalled DNA replication fork.
Materials and methods
Cell culture and treatments
The cell line H9c-2 originated from rat heart was purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA) and used for the generation of the cell line H9c2-CK2α-44 employed in this study [22, 34]. The cell line was cultivated at 37 ºC under a 5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Taastrup, Denmark) supplemented with 10% foetal bovine serum (FBS, Biochrom AG, Berlin, Germany). Cells were added 1 μg/ml doxycycline (Dox, Sigma-Aldrich, Brøndby, Denmark) to induce down-regulation of CK2α expression as previously described [22]. The human osteosarcoma U2OS cell line was purchased from ATCC and cultivated in DMEM supplemented with 10% foetal bovine serum at 37ºC under a 5% CO2. Where indicated, cells were transfected for 72 h with a set of four small interfering RNA duplexes (ON-TARGET plus SMART pools, Dharmacon—Horizon Discovery, Lafayette, CO, USA) directed against human CK2α mRNA or rat ATR mRNA using Lipofectamine RNAiMAX transfection reagent (Thermo Scientific, Waltham, MA, USA). Control experiments were performed employing cells transfected with scramble-siRNA (Dharmacon–Horizon Discovery). The expression of FLAG-CLSPN and HA-CHK1 was obtained by transfecting cells with plasmids coding for FLAG-CLSPN [Addgene plasmid # 12659, [35]] and HA-CHK1 [27], respectively, in the presence of Lipofectamine 3000 transfection reagent (Thermo Scientific) for 48 h following the manufacturer’s recommendations.
Cell synchronization in G0/G1-phase was obtained by growing cells in the presence of 0.1% FBS for 48 h before adding complete growth medium. Cells were subsequently harvested at different time points as indicated in the figures. Hydroxyurea (HU), nocodazole (Noc) and aphidicolin (Aph) were purchased from Sigma-Aldrich. Exposure to 60 J/m2 ultraviolet (UV) irradiation was carried out with the Stratalinker UV Crosslinker (Stratagene, CA, USA).
Cell cycle analysis
Cell cycle analysis was performed with a FACSCalibur flow cytometer (BD Biosciences, Franklin Lake, NJ, USA) after staining of the cells with propidium iodide as previously described [31]. Acquired data were processed by Cell Quest Pro Analysis software (BD Biosciences). For each measurement, 10,000 events were analysed. Values indicated in the graphs are expressed in percentage of total number of cells. Determination of the percentage of cells with reduced/fragmented DNA content (i.e., sub-G1) indicates cells undergoing cell death.
BrdU assay
The assay was carried out using the 5-bromo-2ʹ-deoxyuridine (BrdU) Cell Proliferation Assay kit (6813, Cell Signaling Technology, MA, USA) following the manufacturer’s instructions. In brief, cells were incubated with 3 mM HU for 12 h. They were, then, washed with warm PBS and, subsequently, incubated with growth medium containing BrdU at 37 °C for additional 10 h. After fixation and denaturation, cells were incubated with anti-BrdU for 1 h at room temperature and, subsequently, with anti-mouse IgG, HRP-conjugated for 30 min at room temperature. Conjugates were visualized by adding TMB substrate. Colorimetric reactions were quantified by measuring the absorbance at 450 nm. Background signal-intensity where the incubation with the primary antibody was omitted was subtracted from all measurements.
IncuCyte S3 image capture and analysis
Cells were seeded in 96-well plates in the presence or absence of Dox. 48 h after seeding, cells were added HU or vehicle and imaged using the phase contrast channel in the IncuCyte S3 platform (Sartorius, Göttingen, Germany). Four phase contrast images/well from distinct regions were taken at regular intervals using a 10 × magnification objective. Images were analysed employing the IncuCyte S3 image analysis software and Microsoft Excel software as previously described [34].
Preparation of whole cell lysate and nuclear extract, Western blot analysis, immunoprecipitation, kinase assay and antibodies
Harvested cells were processed for SDS-PAGE and Western blot analysis essentially as previously described [28]. Proteins were detected by incubating PVDF membranes with the following primary antibodies: rabbit polyclonal anti-phospho-NF-κB S529 (ab47395, Abcam, Cambridge, United Kingdom), rabbit monoclonal anti-phospho-CHK1 S345 (2348, Cell Signaling Technology), mouse monoclonal anti-CHK1 (2360, Cell Signaling Technology), rabbit monoclonal anti-cyclin E1 (20808, Cell Signaling Technology), mouse monoclonal anti-p53 (2524, Cell Signaling Technology), rabbit polyclonal anti-phospho-p53 S15 (9284, Cell Signaling Technology), rabbit polyclonal anti-Cdc7 (3603, Cell Signaling Technology), rabbit monoclonal anti-NF-κB (8242, Cell Signaling Technology), rabbit monoclonal anti-CDC45 (11881, Cell Signaling Technology), rabbit monoclonal anti-phospho-histone H2A.X S139 (9718, Cell Signaling Technology), mouse monoclonal anti-α-Tubulin (3873, Cell Signaling Technology), rabbit monoclonal anti-histone H3 (4499, Cell Signaling Technology); rabbit polyclonal anti-cyclin A (sc-751, Santa Cruz Biotechnology, Heidelberg, Germany), mouse monoclonal anti-ATR (sc-515173, Santa Cruz Biotechnology), mouse monoclonal anti-ATRIP (sc-365383, Santa Cruz Biotechnology), mouse monoclonal anti-MCM7 (sc-9966, Santa Cruz Biotechnology), mouse monoclonal anti-CLSPN (sc-376773, Santa Cruz Biotechnology), goat polyclonal anti-MCM3, mouse monoclonal anti-CDK2 (sc-6248, Santa Cruz Biotechnology), mouse monoclonal anti-HDAC2 (sc-9959, Santa Cruz Biotechnology), and mouse monoclonal anti-β-actin (A-5441, Sigma-Aldrich). Rabbit polyclonal anti-CK2α, rabbit polyclonal anti-CK2α’ and mouse monoclonal anti-CK2β were obtained as previously described [22].
Nuclear extracts were prepared essentially as described in [36]. Briefly, cells were resuspended in buffer A [10 mM Hepes, pH 7.9, 10 mM KCl2, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, proteases inhibitor cocktail (Roche, Basel, Switzerland), 100 nM okadaic acid (Sigma-Aldrich)]. After adding 0.1% Triton X-100, cells were incubated for 5 min on ice. Nuclei (P1) were separated from the soluble fraction (S1) by centrifugation (1,300 × g, 5 min, 4 °C). The soluble protein fraction was subjected to centrifugation at 20,000×g (15 min, 4 °C). This resulted in the clarified soluble protein fraction (S2). The P1 nuclear fraction was resuspended in buffer A (washing step), and then lysed in the presence of buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, proteases inhibitor cocktail, 100 nM okadaic acid) on ice for 30 min. The soluble (S3) and insoluble nuclear fractions (P2) were separated by centrifugation (1400×g, 5 min, 4 °C). Pellet P2 was washed once with buffer B and centrifuged at 1700×g, 5 min, 4 °C. The resulting pellet P3 (chromatin-enriched fraction) was resuspended in sample buffer and briefly sonicated before loading into SDS–polyacrylamide gel.
Immunoprecipitation experiments were performed essentially as previously described [37] employing 1 mg whole cell lysate and rabbit monoclonal anti-CDC45 antibody (11881, Cell Signaling Technology), rabbit monoclonal anti-HA antibody (3724, Cell Signaling Technology), rabbit polyclonal anti-ATRIP antibody (A7139, ABclonal Technology, MA, USA), mouse monoclonal anti-CLSPN antibody (sc-376773, Santa Cruz Biotechnology), goat polyclonal anti-CK2α antibody (sc-6479, Santa Cruz Biotechnology) or rabbit polyclonal anti-CK2α antibody as indicated in the figure legends. Protein A-Agarose and protein G-Agarose were purchased from Roche.
Kinase assay was performed essentially as described in [37] employing 10 μg whole cell lysate and 190 μM synthetic peptide RRRDDDSDDD as a substrate. Values shown in Fig. 1D are the result of three independent experiments.
Immunostaining
Cells were grown on cover slips and subsequently incubated with rabbit polyclonal anti-phospho-histone H2A.X S139 (2577, Cell Signaling Technology) followed by incubation with biotinylated swine anti-rabbit IgG (E 0431, Dako, Glostrup, Denmark) and streptavidin-conjugated Alexa 555 (Invitrogen) as previously described [38]. Cells were counterstained with Hoechst 33258 dye (Sigma-Aldrich), analysed with a DMRBE microscope equipped with a Leica DFC420C camera (Leica, Denmark) and processed using ImageJ software (NIH, MD, USA). Quantification of positive signals was carried out by manual counting by two independent investigators.
RNA-sequencing library preparation, sequencing, and data analysis
The followed procedure was based upon our previously published work [22]. In brief, total RNA was extracted from cells using Isol-RNA lysis reagent (AH Diagnostics, Aarhus, Denmark). The RNA concentration, purity and integrity were analysed on Nanodrop and Agilent 2100 Bioanalyzer using the RNA 6000 nano kit (Agilent Technologies, Inc., Santa Clara, CA, USA). RNA used for sample preparation had a RIN ≥ 8.0 and a 28 s/18 s ratio ≥ 1.8. Sample preparation was performed as described in the NEBNext ultra II RNA library prep kit (Illumina). The amplified libraries were validated by Agilent 2100 Bioanalyzer using a DNA 1000 kit from Agilent Technologies and quantified by qPCR using the KaPa Library Kits (KaPa Biosystems, Wilmington, MA, USA). Libraries were loaded on the flow cell 2 × 150 bp sequencing on Illumina Novaseq 6000. For data analysis, samples were first trimmed to remove NEBNext adaptor using bbduk.sh [39] and, subsequently, mapped to the rat transcriptome using salmon [40] version 1.3.0 with transcript annotation from Ensembl ver. 103. Because CHK1 was missing in the Ensembl rat annotation, we manually curated the CHK1 locus and found that CHK1 had been merged with Stt3a in a previous build. We therefore manually assigned the two CHK1 transcripts to the CHK1 gene using a previous CHK1 Ensembl ID (ENSRNOG00000008181) and have contacted Ensembl about this issue. Subsequently, gene counts were obtained by merging transcript counts using tximport [41] and differential gene expression analysed with DESeq2 [42] with shrinkage of fold-changes using apeglm [43]. Following pair-wise comparisons, we took the significantly differentially expressed genes and used them in a SOM analysis to identify gene patterns associated with specific conditions using the kohonen package [44, 45]. Briefly, mean expression values from each condition were scaled and centred around 0 to account for differences in expression between different genes. We then defined a map of 4 by 4 nodes and clustered genes to these nodes using the self-organizing map method. Following that, we clustered the nodes into 12 clusters using hierarchical clustering, to merge similar nodes. We performed pathway analyses on these 12 clusters using clusterProfiler [46] and made plots with enrichplot (https://yulab-smu.top/biomedical-knowledge-mining-book/) and pathview [47]. To visualize patterns across clusters, we selected the top-5 enriched pathways from each cluster and used a dotplot to plot overall patterns. Because some pathways were enriched in multiple clusters, the number of pathways plotted for an individual cluster is sometimes more than 5, but all pathways were in the top-5 enriched pathways in at least one cluster.
Quantitative image-based cytometry (QIBC)
QIBC was performed as previously described [48]. Briefly, images were acquired with a ScanR inverted microscope high-content screening station (Olympus) equipped with wide-field optics, air objective, fast excitation and emission filter-wheel devices for DAPI, FITC, Cy3, and Cy5 wavelengths, an MT20 illumination system, and a digital monochrome Hamamatsu ORCA-Flash 4.0LT CCD camera. Images were acquired in an automated fashion with the ScanR acquisition software (Olympus, 3.2.1). 81 images were acquired containing at least 10,000 cells per condition. Acquisition times for the different channels were adjusted for non-saturated conditions in 12-bit dynamic range, and identical settings were applied to all the samples within one experiment. Images were processed and analysed with ScanR analysis software. First, a dynamic background correction was applied to all images. The DAPI (Sigma-Aldrich) signal was then used for the generation of an intensity-threshold-based mask to identify individual nuclei as main objects. This mask was then applied to analyse pixel intensities in different channels for each individual nucleus. These values were then exported and analysed with TIBCO Software, version 11. This software was used to quantify absolute, median, and average values in cell populations and to generate all color-coded scatter plots. Within one experiment, similar cell numbers were compared for the different conditions (at least 4.000–5.000 cells), and for visualization low x-axis jittering was applied (random displacement of objects along the x axis) to make overlapping markers visible.
Statistical analysis
All values are expressed as mean ± standard deviation. All experiments were independently repeated at least three times. Student’s t test method was applied when compared two groups of data. The statistical significance of values is indicated in the figure legends. All statistical analyses were carried out using Excel software.
Results
CK2α is required for activation of the DNA replication stress checkpoint in myoblasts
Earlier work in our laboratory showed that inducible down-regulation of CK2α in myoblasts (i.e., H9c2-CK2α-44 cells) in the presence of doxycycline (Dox) leads to significant inhibition of cell growth and enhanced sensitivity to induction of mild DNA replication stress [22]. To determine whether CK2α is required for the activation of S-phase checkpoint, we incubated cells with hydroxyurea (HU) for variable lengths of time to induce stalled replication forks. HU inhibits ribonucleotide reductase causing depletion of deoxynucleotide triphosphates and, thereby, arrests active DNA synthesis [49]. Flow cytometry analysis of cells harvested at different time points showed accumulation in G1/S- and S-phases for up to 24 h before resuming the cell cycle suggesting induction of DNA replication block and/or slowing down of fork progression (Fig. 1A). Western blot analysis of whole lysates from cells treated as indicated above showed that HU activated a checkpoint response evidenced by increased ATR-mediated phosphorylation of CHK1 at S345 and concomitant accumulation of cyclin E and cyclin A suggesting cell cycle arrest (Fig. 1B). To examine the DNA replication checkpoint response in cells depleted of CK2α by Dox treatment (Fig. 1C and D), we measured cells’ DNA content by flow cytometry according to treatments indicated in Fig. 1E. The analysis revealed a slightly increased G1 population following treatment with Dox as compared to control cells that confirmed our previous findings [22, 34]. Conversely, cells with down-regulation of CK2α and additionally incubated with HU, exhibited marked reduced response to depletion of deoxynucleotides. Ideally, we would wish to rescue the RNAi phenotype by the expression of the target gene (CK2α) in a form refractory to the shRNA effect. Such an approach is presently complicated due to varying uptake of the cDNA-expressing construct in individual cells, leading to a spectrum of phenotypes within the cell population. Approaches to obtain consistently regulatable expression of both shRNA and cDNA are presently being developed so that the rescue of the RNAi effects can be reliably tested.
We additionally analysed whole extracts by Western blot from cells treated as indicated in Fig. 2A. We found that while in control cells, HU induced marked CHK1 phosphorylation at S345, and upregulation of cyclin E and cyclin A at 24 h treatment, this effect was abrogated following down-regulation of CK2α. Interestingly, while depletion of ATR alone largely abrogated Chk1 phosphorylation at S345, down-regulation of CK2α and ATR together led to a further decline in CHK1 phosphorylation, suggesting that CK2α is involved in ATR-dependent activation of CHK1 in response to replication stress (Fig. 2B). Results obtained from immunofluorescence staining (Fig. 2C and D and Suppl. Fig S1A) confirmed the analysis by Western blot (Fig. 2A) and revealed that approx. 9% and 11% of cells were positively stained for CHK1 S345 at 3 h and 6 h after HU, respectively, whereas only approx. 4% and 6% of cells were positive for CHK1 S345 when CK2α was down-regulated. Overall, these results indicate that CK2α is required for optimal ATR-CHK1-mediated checkpoint activation.
DNA replication stress can be induced by agents and conditions other than HU. Hence, to verify whether the reported effect was linked to DNA replication stress and not specifically to HU treatment, we verified whether aphidicolin treatment (Aph), an inhibitor of DNA polymerases, or exposure to 60 J/m2 UV irradiation [49, 50] would also induce phosphorylation of CHK1 in H9c2-CK2α-44 cells. Cell exposure to Aph or UV irradiation resulted in prompt activation of ATR-CHK1 checkpoint signalling as shown by increasing phosphorylation of CHK1 at S345 (Fig. 2E and Suppl. Fig S2). However, CHK1 phosphorylation was significantly abrogated in cells with down-regulation of CK2α indicating that CK2α is required for the activation of a checkpoint response in cells undergoing DNA replication stress (Fig. 2E).
Global gene expression profiling indicates an important role of CK2α in the regulation of genes controlling DNA replication
To examine CK2α’s role in the regulation of DNA replication and activation of S-phase checkpoint under DNA replication stress, we carried out RNA-sequencing on the H9c2-CK2α-44 myoblast cells [22] treated with either Dox to induce down-regulation of CK2α, HU to induce replication stress, or a combination of both agents and compared to vehicle-treated cells as control. We, then, identified gene clusters associated with each group using self-organizing maps (Fig. 3A) and identified KEGG pathways enriched within each cluster (Fig. 3B). We found that pathways associated with DNA replication and cell cycle were enriched within clusters 4 and 7, that were generally characterized by genes with higher expression in cells treated with HU as compared to controls, but less so in cells treated with both HU and Dox. More specifically, a closer examination of genes within the cell cycle pathway (Fig. 3C, Suppl. Figs S3 and S4) showed that the combination of HU and Dox led to a normalization of the expression of genes associated with DNA replication, such as the minichromosome maintenance proteins (MCMs) 3, 5, 6 and 7, origin recognition complex protein 5 (Orc5), transforming growth factor beta 3 (Tgfb3), double-strand-break repair protein rad21 homolog (Rad21), cyclin-dependent kinase 1 (CDK1), cell division cycle 25A (CDC25A), Wee1 G2 checkpoint kinase (Wee1), cyclin A2 (Ccna2), and cell division cycle 45 (CDC45). These were all up-regulated in HU-treated cells and down-regulated in Dox-treated cells. Conversely, we also observed normalization of expression of genes otherwise down-regulated in cells treated with HU alone, such as the cyclin-dependent kinase inhibitor 1B (Cdkn1b), cell division cycle 14B (Cdc14b), RB transcriptional corepressor like 2 (Rbl2) and SMAD family member 4 (SMAD4).
Altogether, these findings provide molecular evidence as to how the normal cellular response to DNA replication stress, which results in increased expression levels of many of the DNA replication machinery genes, is compromised in cells with perturbed CK2α levels resulting in delayed G1 to S-phase transition and defect S-phase checkpoint activation.
CK2α is required for ATR-CHK1-mediated checkpoint activation in response to DNA replication stress
DNA replication starts at separate origins marked by the presence of ORC-dependent formation of pre-RCs. MCM2-7 protein complex is an important component of the pre-RC and it undergoes phosphorylation by cyclin E-CDK2 and Cdc7-Dbf4 protein kinases [51]. One of the major consequences of this concerted action is the loading of CDC45 which is essential for DNA unwinding and the binding of DNA polymerases to chromatin (Fig. 4A, [52]). MCM2 and MCM7 are direct targets of ATR checkpoint kinase and several lines of evidence suggest that the MCM2-7 complex is an important link between DNA replication and the DNA damage response to preserve genome stability in eukaryotic cells [53, 54].
To further elucidate the role of CK2α in DNA replication checkpoint, we determined the expression levels of several replication factors and proteins involved in checkpoint activation. Analysis of whole lysates from cells treated as indicated in Fig. 4B and C revealed that CK2α down-regulation in HU-treated cells not only impaired the ATR-mediated phosphorylation of CHK1 at S345 but also resulted in reduced expression of CLSPN (53% residual signal) and CDC45 (74% residual signal) as compared to control cells (Fig. 4B). The expression of Cdc7 remained unchanged under the applied experimental conditions. Moreover, lowered expression of CK2α resulted in significantly reduced levels of MCM3 in the absence (16% residual signal) and presence of HU treatment for 6 h (9% residual signal), respectively. Similar results were obtained in the case of MCM7 where we observed 71% and 51% residual signals in the absence and presence of HU treatment for 6 h, respectively, confirming also results from our previous investigations [22]. A similar outcome was observed in cells exposed or not to HU for 24 h (Fig. 4C). We reasoned that decreased phosphorylation of CHK1 at S345 could be a consequence of impaired ATR kinase activity. To verify this, we included the analysis of p53 phosphorylation at S15, which is an amino acid residue targeted by ATR in response to stress signals [55]. However, immunoblot analysis showed that the phosphorylation levels of p53 remained unchanged in cells treated with HU or a combination of HU and Dox. Although we cannot completely exclude the possibility that CK2α depletion negatively affects optimal kinase activity of ATR, results shown in Fig. 4B make it unlikely.
Compelling evidence obtained with human and yeast cells has indicated that CDC45 has ssDNA binding affinity, may modulate DNA replication fork stalling and is likely to be an important target of the ATR-CHK1-mediated S-phase checkpoint [56,57,58]. It has been shown that CDC45 binds several proteins of the MCM2-7 complex including MCM7 [56, 58, 59], which is considered a critical regulator of the S-phase checkpoint [53]. Because of the effect on the expression levels of MCM2-7 proteins observed with CK2α down-regulation (Fig. 4C, [22]), it was of interest to determine whether the interaction between CDC45 and MCM7 is disrupted following induction of DNA replication stress and down-regulation of CK2α. As shown in Fig. 5A, MCM7 co-immunoprecipitated with CDC45 and the signal derived from the complex formation increased concomitantly with the length of exposure of cells to HU from 55% in control cells up to 100% in cells treated with HU for 36 h. We did not observe association with CDK2, consistent with the notion that CDK2 stimulates the ATR-CHK1 pathway and is required for an efficient DNA replication checkpoint response by catalysing the phosphorylation of specific substrates rather than associating with its target proteins [60]. Interestingly, we found that also the signal from the detected CK2α associated with MCM7 and CDC45 was increased under these experimental conditions.
The increased binding between MCM7 and CDC45 observed in cells treated for up to 36 h with HU suggested that this effect could be dependent on the gradual accumulation of cells in S-phase. To verify this, cells were synchronized by serum starvation for 48 h and, upon stimulation with full growth medium, collected at different time intervals as indicated in Fig. 5B. Next, we verified the association between CDC45 and MCM7 employing whole extracts from cells harvested at 0 h, 14 h and 18 h, respectively. Immunoblot analysis revealed that the association between CDC45 and MCM7 increased during S-phase confirming findings reported previously [61]. Most importantly, down-regulation of CK2α caused a significant decrease in the signal relative to the interaction between CDC45 and MCM7 (Fig. 5C). Next, to determine the role of CK2α in the complex formation between MCM7 and CDC45 following HU treatment, we carried out co-immunoprecipitation experiments as shown in Fig. 5D. The signal relative to the association between CDC45 and MCM7 was slightly higher after 4 h of incubation with HU (58% signal in control cells and 65% in cells exposed to HU for 4 h as compared to cells treated with HU for 24 h) and it further increased after 24 h of incubation. Conversely, the signal derived from the detection of these proteins was significantly decreased in cells with reduced levels of CK2α (i.e. 25% and 45% residual signal after treatment with HU for 4 h and 24 h, respectively).
Overall, these results show that CK2α is required for efficient interaction between CDC45 and MCM7 during DNA replication and S-phase checkpoint activation (Fig. 8).
Optimal phosphorylation of CHK1 by ATR requires the coordinated interaction of several replication and checkpoint proteins. MCM7 is required for ATR foci formation by interacting with ATRIP, thus, facilitating ATR tethering to the replication fork and optimal CHK1 phosphorylation in response to ssDNA [53, 62]. Based on this, we determined whether the interaction between MCM7 and ATRIP was affected concomitantly with down-regulation of CK2α and HU treatment. Analysis of immunoprecipitates by Western blot, revealed increased association between MCM7 and ATRIP in cells treated with HU and harvested after 4 h and 24 h, respectively, as compared to control experiments (Fig. 5E). This confirms previous results demonstrating that the association of MCM7 with ATRIP is enhanced in replication checkpoint signalling [62]. Conversely, detection of this complex formation was found significantly reduced in cells with down-regulated CK2α as indicated by the densitometric analysis of protein band signal (Fig. 5E). In line with previous findings, we confirmed stable association between ATR and ATRIP in control cells and no evidence of altered ATR–ATRIP complex formation in response to HU treatment [5, 63,64,65]. Conversely, association between ATRIP and CK2α was not observed under the applied experimental conditions (Fig. 5E). Collectively, these results suggest that MCM7 is closely associated with the ATR–ATRIP complex and although a direct association between ATRIP and CK2α could not been observed, our results suggest that down-regulation of CK2α might negatively impact the stability of the ATR–ATRIP–MCM7 complex formation (Fig. 8).
Different lines of evidence indicate that ATR phosphorylates and might constitutively interact with the adaptor protein CLSPN enabling it to bind CHK1, thus, facilitating ATR-mediated phosphorylation of the effector kinase [58, 66, 67]. Hence, we asked whether endogenous CLSPN associates with ATR, CHK1 and possibly CK2α by performing immunoprecipitation experiments employing anti-CLSPN antibodies. We identified a weak but detectable interaction of endogenous CLSPN with ATR in control cells and cells treated with HU for 4 h. However, the signal derived from their complex formation was not detectable at 24 h of incubation with HU (17% residual signal for ATR detection) nor in cells with down-regulated CK2α (19% residual signal for ATR detection, Fig. 5F). Most importantly, we show for the first time that CK2α is precipitated by anti-CLSPN antibodies and that its down-regulation seems to severely compromise the association between CLSPN and ATR (Fig. 5F). Although we readily observed binding of CLSPN to ATR and CK2α, we could not detect a complex between CLSPN and endogenous CHK1 under the applied experimental conditions. As previous studies suggested such a physical interaction between CLSPN and CHK1, we asked whether lack of detection of this complex in myoblasts could be due to technical limitations. To investigate this, we co-transfected cells with plasmids expressing FLAG-CLSPN and HA-CHK1 and carried out immunoprecipitation experiments with anti-HA antibodies. As shown in Fig. 5G, we readily detected association between FLAG-CLSPN and HA-CHK1, which slightly increased upon 4 h of incubation with HU. Interestingly, decreased expression of CK2α resulted in significantly decreased detection levels of their interaction both in the absence and presence of replication stress.
In subsequent experiments employing whole lysate from control cells, we demonstrated that anti-CK2α antibodies co-precipitated endogenous CLSPN, CHK1, CDC45 and MCM7 and not ATR or ATRIP (Fig. 5H). Collectively, these results show that CK2α associates with essential components of the replisome, which are critical factors in DNA replication and in the activation of checkpoint signalling in response to stalled replication forks (Fig. 8).
To validate key findings reported above with different cells we, additionally, analysed the response to HU treatment following siRNA-mediated silencing of CK2α, in human cells. For this, we employed U2OS cells and incubated them with HU for increasing lengths of time. Flow cytometry-based analysis of the cells showed accumulation at G1/S-phase as early as 6 h after adding the compound and up to 24 h of incubation with HU (Suppl. Fig S5A). Thereafter, the cell cycle was resumed. Next, we transfected the cells with CK2α-siRNA and treated them with 3 mM HU for 4 h. Cell extracts were employed for immunoprecipitation experiments in the presence of anti-CDC45 antibodies (Suppl. Fig S5B). MCM7 co-immunoprecipitated with CDC45 and CK2α and the amount of MCM7 associated with CDC45 increased in HU-treated cells. Conversely, in CK2α-depleted cells, the amount of MCM7 interacting with CDC45 significantly decreased in cells left untreated or only incubated with HU. This indicates that MCM7–CDC45 interaction is dependent on the presence of CK2α as observed in myoblasts (Fig. 5D). In experiments conducted with myoblasts, we observed interaction between CLSPN and ATR (Fig. 5F). When we investigated their association in U2OS cells, however, we were able to detect a complex between CLSPN and CK2α but not between CLSPN and ATR (Suppl. Fig S5C). We additionally conducted reciprocal immunoprecipitation experiments essentially as shown in Fig. 5H using anti-CK2α antibodies. Experiments yielded results consistent with those shown in Fig. 5H, confirming that also in U2OS cells, CK2α interacts with CLSPN, CHK1, CDC45 and MCM7 (Suppl. Fig S5D).
CK2α is important for the recruitment and/or stability of CLSPN and CDC45 to chromatin during induction of checkpoint signalling
In response to replication block, ATR and CLSPN are both required for optimal activation of CHK1 [7, 68, 69]. Under these conditions, CHK1 is recruited to sites of DNA damage in a CLSPN-dependent manner where it is phosphorylated by ATR [11]. Furthermore, it has been established that CHK1 binds to chromatin in unperturbed cells but dissociates from it to phosphorylate downstream effectors in response to DNA damage [70,71,72]. To investigate the cellular localization of CK2α’s interaction partners following induction of replication stress, we fractionated whole cell lysates. We separated cytoplasmic proteins (S2) from soluble nuclear proteins (S3) and a chromatin-enriched fraction (P3, Fig. 6A) essentially as described in [36]. Western blot analysis of these different fractions revealed that ATR, ATRIP and Cdc7 were largely detected in the chromatin-enriched fraction supporting the notion that these proteins are primarily associated with chromatin. However, no differences in their binding were seen under the applied experimental conditions (Fig. 6B and C). This is consistent with the hypothesis that at least in the case of ATR and ATRIP, the level of recruitment to chromatin does not increase following induction of DNA replication stress. These proteins might, instead, undergo a change in the mode by which they bind to chromatin as previously suggested [64]. This possibility should not be excluded also in the case of Cdc7 where a marginally increased binding to chromatin has been reported in experiments with HU and chromatin isolation in low salt conditions [73, 74]. Next, we investigated the expression of CLSPN in soluble nuclear and chromatin-enriched fractions (Fig. 6C). We found that the majority of CLSPN was associated with chromatin in control cells and the amount did not change in response to HU as previously reported [74]. Conversely, the levels of CLSPN in the P3 fraction decreased significantly in cells with down-regulated CK2α and in the absence or presence of HU. In agreement with previous studies [1], CDC45 was detected in all three fractions. Part of this protein localized in the S3 and P3 fractions in response to HU. However, as observed for CLSPN, the levels of CDC45 in the soluble nuclear and chromatin-enriched fractions decreased considerably when CK2α was down-regulated (Fig. 6C). Analysis of endogenous CHK1 revealed that this effector kinase was present in the cytoplasmic, nuclear and chromatin fractions as previously described [72, 75] whereas the phosphorylated form was more abundant in the soluble nuclear fraction than in the P3 fraction in cells treated with HU. This supports the notion that CHK1 can bind chromatin in unperturbed cells but rapidly dissociates from it in response to DNA damage to facilitate transmission of the DNA damage signal to downstream target proteins [72, 75]. Interestingly, the amounts of CHK1 and phosphorylated CHK1 in the S3 and P3 fractions were decreased in cells with down-regulated CK2α (Fig. 6C). As an important control for the fractionation method applied in our investigations, we exclusively observed expression of α-Tubulin in the S2 fraction and not in the P3 fraction (Fig. 6B) making unlikely a cross contamination between soluble proteins present in the S2 fraction and our nuclear preparations.
Overall, these results indicate that CK2α is required for maintaining proper association of CLSPN, CDC45 and CHK1 with chromatin and/or that this kinase is essential for preserving their stability both in unperturbed and replication stress-induced conditions.
Cells with reduced expression of CK2α show delayed stalled fork recovery and defects in S-phase checkpoint in response to deprivation of deoxynucleotides
To evaluate the ability of the cells to recover from replication block induced in the presence of HU, myoblasts left untreated or exposed to Dox for 72 h were incubated with 3 mM HU in the last 12 h of incubation time. Six hours prior to harvesting, cells were trapped in mitosis by adding 0.2 μg/ml nocodazole (Noc). As expected, the analysis of cells by flow cytometry showed that 16.02% of control cells treated with nocodazole accumulated in G2/M-phase whereas additional down-regulation of CK2α resulted in 13.15% accumulation of cells in G2/M-phase (Fig. 7A). This supports the notion that cells with down-regulated CK2α expression display delayed cell cycle progression as previously observed [22, 34].
Exposure to HU resulted in 10.02% accumulation of cells in G2/M-phase whereas additional treatment with nocodazole led to a 10.13% accumulation of cells in G2/M-phase. Cells with down-regulation of CK2α displayed a slightly, but reproducible, decreased number of cells in G2/M-phase (9.28% in the absence of nocodazole and 8.69% in the presence of it, respectively). This suggests that cells with down-regulated expression of CK2α undergo a prolonged arrest in G1/S-phase and/or have difficulties to resume cell cycle progression after fork arrest in the presence of HU. To verify this, we investigated the rate of cellular DNA synthesis by measuring BrdU incorporation in control and CK2α-depleted cells, respectively, (Fig. 7B). We treated cells with HU for 12 h and then measured BrdU incorporation after the removal of HU. In the absence of HU, fewer cells were in S-phase after CK2α down-regulation suggesting a slower proliferation rate. After treatment with HU, CK2α-down-regulated cells had a significantly reduced BrdU incorporation as compared to cells incubated with HU alone. This suggests that CK2α is important for S-phase checkpoint recovery following treatment with HU and underlines the functional role of this protein kinase in maintaining replication potential during unperturbed DNA replication and in response to replication stress. We cannot, however, exclude the possibility that this protein kinase might, additionally, control cell cycle progression through S-phase.
The histone variant H2AX has been implicated in the maintenance of genomic stability in response to induction of DNA double-strand breaks (DSBs) signalled by its phosphorylation catalysed by a phosphatidylinositol 3-OH-kinase-related kinase, mainly ATM [1, 77]. However, compelling evidence has indicated that H2AX is also phosphorylated in an ATR-dependent manner in response to stalled fork formation making it a sensitive indicator of both DNA damage and DNA replication stress [77, 78]. Based on this, we asked whether down-regulation of CK2α affects the phosphorylation levels of H2AX. In this respect, it has been shown that CHK1 inhibition or its siRNA-mediated down-regulation causes formation of ssDNA with increased levels of RPA bound to chromatin, which triggers rapid ATR-mediated phosphorylation of H2AX (γ-H2AX) in exponentially growing cells [79]. Hence, to test whether down-regulation of CK2α is associated with changes in the levels of γ-H2AX, we stained cells with anti-phospho-H2AX (S139, Fig. 7C) and quantified the signal as indicated in Fig. 7D. Exposure of cells to HU for 3 h and 6 h, respectively, resulted in increased pan-nuclear phosphorylation of H2AX following replication stress induction as compared to control cells. Unexpectedly, down-regulation of CK2α caused a significant reduction in γ-H2AX signal suggesting compromised signalling to the checkpoint machinery. In support of results shown in Fig. 7C and D, we additionally performed Western blot analysis of chromatin-enriched protein fractions (Fig. 7E) and super-resolution microscopy (QIBC) analysis of cells treated as indicated in Suppl. Fig S6 and immunolabelled with anti-γ-H2AX antibody to mark the phosphorylation of H2AX during the cell cycle. As shown in Fig. 7E and Suppl. Fig S6, γ-H2AX signal was significantly lower in cells with reduced levels of CK2α and exposed to HU as compared to cells incubated with HU alone unequivocally indicating that down-regulation of CK2α prevents phosphorylation of H2AX in response to DNA replication stress.
The newly discovered connection between CK2α and DNA replication stress response prompted us to also examine the effect on cell proliferation. We monitored proliferation at extensive lengths of time employing the IncuCyte S3 live-cell analysis system. Figure 7F shows that cells incubated with HU alone displayed a significant reduction in the proliferation rate as compared to control cells. When CK2α expression was also reduced, cells responded with a further reduction in proliferation with respect to control cells and those treated with Dox or HU, respectively.
Taken together, results shown in this study provide compelling evidence that cells with reduced levels of CK2α do not progress from G1 to S-phase at the same pace when subjected to HU-induced replication stress. Our data suggest that CK2α plays a specialized role in preserving replication fork integrity by ensuring the stable association of specific replication fork factors. Consequently, cells with reduced levels of CK2α experience (i) less efficient or delayed entry into S-phase, (ii) compromised S-phase checkpoint activation in response to DNA replication stress and (iii) defective recovery of stalled replication forks at the cost of cell growth.
Discussion
In this study, we have identified a novel function of CK2α as a protein kinase essential in DNA replication checkpoint signalling. Depletion of CK2α correlates with a significant reduction in the phosphorylation of CHK1 suggesting impaired activation of the ATR-CHK1 signalling cascade. In response to replication stress, ATR activation results in its recruitment to RPA-coated ssDNA in a process which depends on its interaction partner ATRIP. From the analysis of p53 phosphorylation at S15 we concluded that ATR kinase activity per se remains unaltered in cells depleted of CK2α. However, we cannot exclude the possibility that optimal activation of ATR cannot be reached in cells depleted of CK2α as this event is a multi-step process involving several checkpoint proteins. In this respect, one of the best characterized activators of ATR is TopBP1 which contains an ATR-activation domain that stimulates ATR kinase activity [80]. Interestingly, CK2 has been shown to regulate the stability of TopBP1 by phosphorylating histone demethylase PHF8 which binds TopBP1 preventing its degradation to maintain genome stability [81]. Hence, the involvement of TopBP1 in the CK2α-mediated regulation of ATR-CHK1 signalling axis is an attractive possibility that warrants further work, in the future.
Among the array of factors present at the replication fork that contribute to the cellular response to DNA replication stress, we have identified several proteins regulated by CK2α. CLSPN, a checkpoint clamp loader, is necessary for ATR-dependent activation of CHK1 [66]. We found that signal derived from its association with ATR is significantly impaired in cells with down-regulation of CK2α (Fig. 5F). This could be due to CLSPN’s reduced expression under experimental conditions indicated in Figs. 4 and 6. However, the ATR-CHK1 signalling pathway is subjected to several layers of regulation and while a complex has been detected between human CLSPN and ATR, it has not to be excluded that other proteins such as TopBP1 [12] and AND-1 [82], which have been shown to bind ssDNA and be important regulators for efficient CHK1 activation, could be subjected to CK2α regulation as well. Additionally, CLSPN expression is regulated by the proteasome-mediated degradation machinery and down-regulation or inhibition of CHK1 have been found to decrease CLSPN stability implying a reciprocal regulation during the cell cycle [83]. CK2α-mediated phosphorylation of CLSPN could also contribute to maintain its protein stability as CLSPN’s amino acid sequence displays several putative CK2-dependent phosphorylation sites. We attempted to verify CLSPN-ATR binding also in U2OS cells. However, we could not demonstrate their association, in accordance with previous studies [66]. This reinforces the notion that their complex formation can be transient and that there might be some differences in the strength of their binding among cell types. Nonetheless, our data suggest that both CLSPN and CK2α are required to sustain CHK1 activation during DNA replication stress response and that reduced levels of CK2α may destabilize this complex formation resulting in accelerated degradation of CLSPN and impaired activation of CHK1.
Interestingly, we found that CK2α associates with CHK1. We previously showed by gel filtration analysis combined to immunoprecipitation assays that CHK1 mainly interacts with the CK2β isoform of protein kinase CK2 and only marginally with CK2α in cancer cells [27]. Cells with reduced levels of CK2α display decreased CK2 kinase activity and reduced expression levels of CK2β as previously observed (Fig. 1C, D, [22]). Whereas the contribution of CK2β to the association between CHK1 and CK2α in myoblasts remains to be investigated, it is not to be excluded that the presence of CHK1 in anti-CK2α immunoprecipitates might also be due to the presence of another replisome factor co-precipitating with CK2α.
The correct regulation of CHK1 also depends on other proteins such as MCM7. This helicase has been shown to be a direct target of the ATR-mediated signalling cascade making it an attractive candidate linking the DNA replication machinery to checkpoint activation in S-phase (reviewed in [11]). We demonstrated that CK2α co-precipitates with MCM7 and its co-factor CDC45 and their complex formation increases as cells accumulate in S-phase. This suggests that CK2α is required for replication initiation and, possibly, the elongation step of DNA replication. Moreover, we show that signal relative to the association between MCM7 and CDC45 is significantly decreased in cells with reduced levels of CK2α. While this indicates that CK2α could contribute to stabilize their interaction we cannot exclude that lack of detection of this complex formation may result from decreased expression levels of MCM7 in cells with down-regulated CK2α. This was previously reported by us in in vitro and in vivo investigations [22] and it is consistent with the possibility that CK2α might directly or indirectly protect MCM7 from proteasome-mediated degradation. In support of this, Buchsbaum et al. [84] showed that endogenous MCM7 can be polyubiquitinated and that proteasome-mediated inhibition increases the intracellular amounts. Regulation of MCM7 expression as well as the other members of the MCM2-7 complex has not been fully investigated and can occur at multiple levels. Chuang et al. [85] identified two new mechanisms that regulate MCM proteins expression showing that the stoichiometry of the MCM components is controlled post-transcriptionally at both mRNA and protein levels. Interestingly, Montagnoli et al. [86] showed that CK2 phosphorylates MCM2 at a highly conserved canonical consensus sequence. Hence, it is not to be excluded that MCM7 might as well serve as a substrate for protein kinase CK2. Hence, future experiments will be pivotal for understanding how CK2α controls the expression of eukaryotic MCM helicases. This knowledge will provide further insights into the mechanism by which CK2α regulates DNA replication under normal as well as perturbed conditions affecting S-phase.
Biochemical fractionation separating soluble from chromatin-bound proteins showed that CDC45 is present in all three fractions as reported in previous studies [1, 59, 61]. Whereas the cytosolic fraction of CDC45 remained unchanged under experimental conditions shown in Fig. 6B and C, we reported evidence of CDC45 accumulation in the nucleoplasm and in the fraction of proteins associated with chromatin following incubation with HU. This pattern of expression of CDC45 in the nuclear fraction changed upon down-regulation of CK2α. This raises several possibilities that could potentially explain the decrease in CDC45 expression in cells with reduced levels of CK2α including (i) dissociation of CDC45 from chromatin, (ii) its enhanced degradation and/or (iii) altered expression mediated by a transcription factor. It is unlikely that lack of CK2α causes detachment of CDC45 from chromatin as we do not observe a concomitant increase of signal in the nucleoplasm or cytosol. We cannot, however, exclude the possibility of increased degradation. CDC45 contains several PEST and KEN domains that facilitate its breakdown [87] and this might suggest that its half-life is just sufficient to cover one S-phase [88]. The possibility that a transcription factor might be negatively affected in cells with reduced levels of CK2α is an attractive alternative. CDC45, but also MCM proteins, have been shown to be under the control of E2F transcription factors [89,90,91,92,93] through mechanisms in part dependent on the activation of cyclin E-CDK2, which is one of the major upstream regulators of the retinoblastoma (Rb)/E2F complex [89]. Interestingly, we previously demonstrated that cells with down-regulated expression of CK2α display significantly reduced kinase activity of the cyclin E-CDK2 complex and concomitantly, inhibition of E2F transcriptional activity [22, 34]. Finally, CDK2 acts in concert with Cdc7 to facilitate loading of CDC45 onto the DNA [94]. We have not observed differences in the amount of Cdc7 associated with chromatin in the presence or absence of CK2α, however, this does not exclude the possibility that CK2α might regulate the kinase activity of Cdc7. In this respect, CK2α has been shown to phosphorylate nuclear phosphoglycerate kinase (PGK) 1 kinase resulting in interaction of PGK1 and Cdc7 and promoting the recruitment of DNA helicases to replication origins [95].
Apart from CHK1, ATR phosphorylates other checkpoint proteins at stalled replication forks including the histone variant H2AX at S139 [11]. This occurs mostly in early S-phase [96]. Interestingly, we observed that H2AX was not phosphorylated in cells with down-regulation of CK2α. Given the effect on essential replication factors, we hypothesized that cells with down-regulated CK2α and exposed to HU would display elevated levels of spontaneous DNA damage and elevated γ-H2AX signal. This was, however, not the case (Fig. 7). In line with our findings, Syljuåsen et al. [79] showed that phosphorylation of H2AX is prevented in cells treated with CDK inhibitors and shRNA-mediated down-regulation of CDK2, respectively, in response to CHK1 inhibition. Moreover, Gagou et al. [78] reported evidence that H2AX phosphorylation occurs at sites of stalled forks and that this is strictly dependent on the presence of CDC45. Although we did not detect a significant change in the viability of the cells, results shown in Fig. 7 indicate, altogether, that cells are failing to recover from HU-induced arrest and slowly lose proliferation potential when CK2α is down-regulated. Since phosphorylation of histone H2AX is implicated in the maintenance of DNA stability, decreased accumulation of γ-H2AX could just be the consequence of incorrect assembly and/or expression of DNA repair complexes and compromised checkpoint signalling (Fig. 8).
Conclusion
Overall, results presented in this study provide novel insights into critical mechanisms which control DNA synthesis and activation of DNA replication checkpoint and suggest that CK2α is a key player in these processes by ensuring the stability and/or association of protein factors present at DNA replication forks. Most importantly, altered expression of CK2α could sensitize cells to additional DNA damaging stresses, induce aberrant cell cycle progression and augment cell death.
Data availability
RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI under accession number: E-MTAB-10752.
References
Aparicio T, Ibarra A, Mendez J (2006) Cdc45-MCM-GINS, a new power player for DNA replication. Cell Div 1:18. https://doi.org/10.1186/1747-1028-1-18
Moyer SE, Lewis PW, Botchan MR (2006) Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc Natl Acad Sci USA 103(27):10236–10241. https://doi.org/10.1073/pnas.0602400103
Sawa M, Masai H (2009) Drug design with Cdc7 kinase: a potential novel cancer therapy target. Drug Des Dev Ther 2:255–264. https://doi.org/10.2147/dddt.s4303
Leman AR, Noguchi E (2013) The replication fork: understanding the eukaryotic replication machinery and the challenges to genome duplication. Genes (Basel) 4(1):1–32. https://doi.org/10.3390/genes4010001
Zou L, Elledge SJ (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300(5625):1542–1548. https://doi.org/10.1126/science.1083430
Ball HL, Myers JS, Cortez D (2005) ATRIP binding to replication protein A-single-stranded DNA promotes ATR–ATRIP localization but is dispensable for Chk1 phosphorylation. Mol Biol Cell 16(5):2372–2381. https://doi.org/10.1091/mbc.e04-11-1006
Kumagai A, Dunphy WG (2000) Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol Cell 6(4):839–849. https://doi.org/10.1016/s1097-2765(05)00092-4
Jeong SY, Kumagai A, Lee J, Dunphy WG (2003) Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of Chk1 during ATR-mediated activation. J Biol Chem 278(47):46782–46788. https://doi.org/10.1074/jbc.M304551200
Kumagai A, Dunphy WG (2003) Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. Nat Cell Biol 5(2):161–165. https://doi.org/10.1038/ncb921
Lee J, Kumagai A, Dunphy WG (2003) Claspin, a Chk1-regulatory protein, monitors DNA replication on chromatin independently of RPA, ATR, and Rad17. Mol Cell 11(2):329–340. https://doi.org/10.1016/s1097-2765(03)00045-5
Petermann E, Caldecott KW (2006) Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 5(19):2203–2209. https://doi.org/10.4161/cc.5.19.3256
Liu S, Bekker-Jensen S, Mailand N, Lukas C, Bartek J, Lukas J (2006) Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation. Mol Cell Biol 26(16):6056–6064. https://doi.org/10.1128/MCB.00492-06
Zhao H, Piwnica-Worms H (2001) ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21(13):4129–4139. https://doi.org/10.1128/MCB.21.13.4129-4139.2001
Lanz MC, Dibitetto D, Smolka MB (2019) DNA damage kinase signaling: checkpoint and repair at 30 years. EMBO J 38(18):e101801. https://doi.org/10.15252/embj.2019101801
Lecona E, Fernandez-Capetillo O (2018) Targeting ATR in cancer. Nat Rev Cancer 18(9):586–595. https://doi.org/10.1038/s41568-018-0034-3
Tawfic S, Yu S, Wang H, Faust R, Davis A, Ahmed K (2001) Protein kinase CK2 signal in neoplasia. Histol Histopathol 16(2):573–582. https://doi.org/10.14670/HH-16.573
Guerra B, Issinger OG (1999) Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20(2):391–408. https://doi.org/10.1002/(SICI)1522-2683(19990201)20:2%3c391::AID-ELPS391%3e3.0.CO;2-N
Guerra BaIO-G (2013) CK2: a global regulator of cell survival. Protein kinase CK2. John Wiley & Sons Inc, Oxford, pp 239–266
Wang H, Davis A, Yu S, Ahmed K (2001) Response of cancer cells to molecular interruption of the CK2 signal. Mol Cell Biochem 227(1–2):167–174
Ahmed K, Gerber DA, Cochet C (2002) Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 12(5):226–230. https://doi.org/10.1016/s0962-8924(02)02279-1
Bibby AC, Litchfield DW (2005) The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta. Int J Biol Sci 1(2):67–79. https://doi.org/10.7150/ijbs.1.67
Schaefer S, Doktor TK, Frederiksen SB, Chea K, Hlavacova M, Bruun GH et al (2019) Down-regulation of CK2alpha correlates with decreased expression levels of DNA replication minichromosome maintenance protein complex (MCM) genes. Sci Rep 9(1):14581. https://doi.org/10.1038/s41598-019-51056-5
Lou DY, Dominguez I, Toselli P, Landesman-Bollag E, O’Brien C, Seldin DC (2008) The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol 28(1):131–139. https://doi.org/10.1128/MCB.01119-07
Xu X, Toselli PA, Russell LD, Seldin DC (1999) Globozoospermia in mice lacking the casein kinase II alpha’ catalytic subunit. Nat Genet 23(1):118–121. https://doi.org/10.1038/12729
Litchfield DW, Luscher B (1993) Casein kinase II in signal transduction and cell cycle regulation. Mol Cell Biochem 127–128:187–199. https://doi.org/10.1007/BF01076770
Pepperkok R, Lorenz P, Ansorge W, Pyerin W (1994) Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle. J Biol Chem 269(9):6986–6991
Guerra B, Issinger OG, Wang JY (2003) Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2. Oncogene 22(32):4933–4942. https://doi.org/10.1038/sj.onc.1206721
Yde CW, Olsen BB, Meek D, Watanabe N, Guerra B (2008) The regulatory beta-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis. Oncogene 27(37):4986–4997. https://doi.org/10.1038/onc.2008.146
Loizou JI, El-Khamisy SF, Zlatanou A, Moore DJ, Chan DW, Qin J et al (2004) The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks. Cell 117(1):17–28. https://doi.org/10.1016/s0092-8674(04)00206-5
Melander F, Bekker-Jensen S, Falck J, Bartek J, Mailand N, Lukas J (2008) Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J Cell Biol 181(2):213–226. https://doi.org/10.1083/jcb.200708210
Olsen BB, Issinger OG, Guerra B (2010) Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells. Oncogene 29(45):6016–6026. https://doi.org/10.1038/onc.2010.337
Olsen BB, Wang SY, Svenstrup TH, Chen BP, Guerra B (2012) Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage. BMC Mol Biol 13:7. https://doi.org/10.1186/1471-2199-13-7
Guerra B, Iwabuchi K, Issinger OG (2014) Protein kinase CK2 is required for the recruitment of 53BP1 to sites of DNA double-strand break induced by radiomimetic drugs. Cancer Lett 345(1):115–123. https://doi.org/10.1016/j.canlet.2013.11.008
Guerra B, Dembic M, Siddiqui MA, Dominguez I, Ceppi P, Andresen BS (2020) Down-regulation of CK2alpha leads to up-regulation of the cyclin-dependent kinase inhibitor p27(KIP1) in conditions unfavorable for the growth of myoblast cells. Cell Physiol Biochem 54(6):1177–1198. https://doi.org/10.33594/000000308
Peschiaroli A, Dorrello NV, Guardavaccaro D, Venere M, Halazonetis T, Sherman NE et al (2006) SCFbetaTrCP-mediated degradation of claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 23(3):319–329. https://doi.org/10.1016/j.molcel.2006.06.013
Mendez J, Stillman B (2000) Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol 20(22):8602–8612. https://doi.org/10.1128/mcb.20.22.8602-8612.2000
Guerra B, Siemer S, Boldyreff B, Issinger OG (1999) Protein kinase CK2: evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles. FEBS Lett 462(3):353–357. https://doi.org/10.1016/s0014-5793(99)01553-7
Olsen BB, Guerra B (2008) Ability of CK2beta to selectively regulate cellular protein kinases. Mol Cell Biochem 316(1–2):115–126. https://doi.org/10.1007/s11010-008-9817-2
Bushnell B (2014) BBMap: a fast, accurate, splice-aware aligner. United States. http://www.osti.gov/servlets/purl/1241166
Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 14(4):417–419. https://doi.org/10.1038/nmeth.4197
Soneson C, Love MI, Robinson MD (2015) Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4:1521. https://doi.org/10.12688/f1000research.7563.2
Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https://doi.org/10.1186/s13059-014-0550-8
Zhu A, Ibrahim JG, Love MI (2019) Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35(12):2084–2092. https://doi.org/10.1093/bioinformatics/bty895
Wehrens R, Buydens LM (2007) Self- and super-organizing maps in R: the Kohonen package. J Stat Softw 21:1–19
Wehrens R, Kruisselbrink J (2018) Flexible self-organizing maps in Kohonen 3.0. J Stat Softw 87:1–18
Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284–287. https://doi.org/10.1089/omi.2011.0118
Luo W, Brouwer C (2013) Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29(14):1830–1831. https://doi.org/10.1093/bioinformatics/btt285
Somyajit K, Gupta R, Sedlackova H, Neelsen KJ, Ochs F, Rask MB et al (2017) Redox-sensitive alteration of replisome architecture safeguards genome integrity. Science 358(6364):797–802. https://doi.org/10.1126/science.aao3172
Vesela E, Chroma K, Turi Z, Mistrik M (2017) Common chemical inductors of replication stress: focus on cell-based studies. Biomolecules. https://doi.org/10.3390/biom7010019
Ward IM, Minn K, Chen J (2004) UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress. J Biol Chem 279(11):9677–9680. https://doi.org/10.1074/jbc.C300554200
Kelly TJ, Brown GW (2000) Regulation of chromosome replication. Annu Rev Biochem 69:829–880. https://doi.org/10.1146/annurev.biochem.69.1.829
Walter J, Newport J (2000) Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. Mol Cell 5(4):617–627. https://doi.org/10.1016/s1097-2765(00)80241-5
Cortez D, Glick G, Elledge SJ (2004) Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc Natl Acad Sci USA 101(27):10078–10083. https://doi.org/10.1073/pnas.0403410101
Ibarra A, Schwob E, Mendez J (2008) Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc Natl Acad Sci USA 105(26):8956–8961. https://doi.org/10.1073/pnas.0803978105
Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137(4):609–622. https://doi.org/10.1016/j.cell.2009.04.050
Liu P, Barkley LR, Day T, Bi X, Slater DM, Alexandrow MG et al (2006) The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanism. J Biol Chem 281(41):30631–30644. https://doi.org/10.1074/jbc.M602982200
Bruck I, Kaplan DL (2013) Cdc45 protein-single-stranded DNA interaction is important for stalling the helicase during replication stress. J Biol Chem 288(11):7550–7563. https://doi.org/10.1074/jbc.M112.440941
Broderick R, Rainey MD, Santocanale C, Nasheuer HP (2013) Cell cycle-dependent formation of Cdc45-Claspin complexes in human cells is compromized by UV-mediated DNA damage. FEBS J 280(19):4888–4902. https://doi.org/10.1111/febs.12465
Takaya J, Kusunoki S, Ishimi Y (2013) Protein interaction and cellular localization of human CDC45. J Biochem 153(4):381–388. https://doi.org/10.1093/jb/mvt004
Bacevic K, Lossaint G, Achour TN, Georget V, Fisher D, Dulic V (2017) Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage. Sci Rep 7(1):13429. https://doi.org/10.1038/s41598-017-12868-5
Bauerschmidt C, Pollok S, Kremmer E, Nasheuer HP, Grosse F (2007) Interactions of human Cdc45 with the Mcm2-7 complex, the GINS complex, and DNA polymerases delta and epsilon during S phase. Genes Cells 12(6):745–758. https://doi.org/10.1111/j.1365-2443.2007.01090.x
Tsao CC, Geisen C, Abraham RT (2004) Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signaling. EMBO J 23(23):4660–4669. https://doi.org/10.1038/sj.emboj.7600463
Ball HL, Cortez D (2005) ATRIP oligomerization is required for ATR-dependent checkpoint signaling. J Biol Chem 280(36):31390–31396. https://doi.org/10.1074/jbc.M504961200
Bomgarden RD, Yean D, Yee MC, Cimprich KA (2004) A novel protein activity mediates DNA binding of an ATR–ATRIP complex. J Biol Chem 279(14):13346–13353. https://doi.org/10.1074/jbc.M311098200
Cortez D, Guntuku S, Qin J, Elledge SJ (2001) ATR and ATRIP: partners in checkpoint signaling. Science 294(5547):1713–1716. https://doi.org/10.1126/science.1065521
Kumagai A, Kim SM, Dunphy WG (2004) Claspin and the activated form of ATR–ATRIP collaborate in the activation of Chk1. J Biol Chem 279(48):49599–49608. https://doi.org/10.1074/jbc.M408353200
Smits VAJ, Cabrera E, Freire R, Gillespie DA (2019) Claspin-checkpoint adaptor and DNA replication factor. FEBS J 286(3):441–455. https://doi.org/10.1111/febs.14594
Chini CC, Chen J (2003) Human claspin is required for replication checkpoint control. J Biol Chem 278(32):30057–30062. https://doi.org/10.1074/jbc.M301136200
Lin SY, Li K, Stewart GS, Elledge SJ (2004) Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation. Proc Natl Acad Sci U S A 101(17):6484–6489. https://doi.org/10.1073/pnas.0401847101
Stracker TH, Usui T, Petrini JH (2009) Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) 8(9):1047–1054. https://doi.org/10.1016/j.dnarep.2009.04.012
Smits VA (2006) Spreading the signal: dissociation of Chk1 from chromatin. Cell Cycle 5(10):1039–1043. https://doi.org/10.4161/cc.5.10.2761
Smits VA, Reaper PM, Jackson SP (2006) Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 16(2):150–159. https://doi.org/10.1016/j.cub.2005.11.066
Tenca P, Brotherton D, Montagnoli A, Rainoldi S, Albanese C, Santocanale C (2007) Cdc7 is an active kinase in human cancer cells undergoing replication stress. J Biol Chem 282(1):208–215. https://doi.org/10.1074/jbc.M604457200
Rainey MD, Harhen B, Wang GN, Murphy PV, Santocanale C (2013) Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpoint. Cell Cycle 12(10):1560–1568. https://doi.org/10.4161/cc.24675
Huh J, Piwnica-Worms H (2013) CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 33(2):213–226. https://doi.org/10.1128/MCB.00847-12
Schwarzerova K, Bellinvia E, Martinek J, Sikorova L, Dostal V, Libusova L et al (2019) Tubulin is actively exported from the nucleus through the Exportin1/CRM1 pathway. Sci Rep 9(1):5725. https://doi.org/10.1038/s41598-019-42056-6
Ward IM, Chen J (2001) Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 276(51):47759–47762. https://doi.org/10.1074/jbc.C100569200
Gagou ME, Zuazua-Villar P, Meuth M (2010) Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Biol Cell 21(5):739–752. https://doi.org/10.1091/mbc.E09-07-0618
Syljuasen RG, Sorensen CS, Hansen LT, Fugger K, Lundin C, Johansson F et al (2005) Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 25(9):3553–3562. https://doi.org/10.1128/MCB.25.9.3553-3562.2005
Kumagai A, Lee J, Yoo HY, Dunphy WG (2006) TopBP1 activates the ATR–ATRIP complex. Cell 124(5):943–955. https://doi.org/10.1016/j.cell.2005.12.041
Feng H, Lu J, Song X, Thongkum A, Zhang F, Lou L et al (2020) CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication. Nucleic Acids Res 48(19):10940–10952. https://doi.org/10.1093/nar/gkaa756
Hao J, de Renty C, Li Y, Xiao H, Kemp MG, Han Z et al (2015) And-1 coordinates with Claspin for efficient Chk1 activation in response to replication stress. EMBO J 34(15):2096–2110. https://doi.org/10.15252/embj.201488016
Chini CC, Wood J, Chen J (2006) Chk1 is required to maintain claspin stability. Oncogene 25(30):4165–4171. https://doi.org/10.1038/sj.onc.1209447
Buchsbaum S, Morris C, Bochard V, Jalinot P (2007) Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle. Oncogene 26(35):5132–5144. https://doi.org/10.1038/sj.onc.1210314
Chuang CH, Yang D, Bai G, Freeland A, Pruitt SC, Schimenti JC (2012) Post-transcriptional homeostasis and regulation of MCM2-7 in mammalian cells. Nucleic Acids Res 40(11):4914–4924. https://doi.org/10.1093/nar/gks176
Montagnoli A, Valsasina B, Brotherton D, Troiani S, Rainoldi S, Tenca P et al (2006) Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J Biol Chem 281(15):10281–10290. https://doi.org/10.1074/jbc.M512921200
Pollok S, Grosse F (2007) Cdc45 degradation during differentiation and apoptosis. Biochem Biophys Res Commun 362(4):910–915. https://doi.org/10.1016/j.bbrc.2007.08.069
Pollok S, Bauerschmidt C, Sanger J, Nasheuer HP, Grosse F (2007) Human Cdc45 is a proliferation-associated antigen. FEBS J 274(14):3669–3684. https://doi.org/10.1111/j.1742-4658.2007.05900.x
Arata Y, Fujita M, Ohtani K, Kijima S, Kato JY (2000) Cdk2-dependent and -independent pathways in E2F-mediated S phase induction. J Biol Chem 275(9):6337–6345. https://doi.org/10.1074/jbc.275.9.6337
Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS et al (1998) E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 12(14):2120–2130. https://doi.org/10.1101/gad.12.14.2120
Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H et al (1999) Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18(14):2299–2309. https://doi.org/10.1038/sj.onc.1202544
Burkhart DL, Wirt SE, Zmoos AF, Kareta MS, Sage J (2010) Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions. PLoS Genet 6(6):e1001003. https://doi.org/10.1371/journal.pgen.1001003
Woo RA, Poon RY (2003) Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2(4):316–324
Walter JC (2000) Evidence for sequential action of cdc7 and cdk2 protein kinases during initiation of DNA replication in Xenopus egg extracts. J Biol Chem 275(50):39773–39778. https://doi.org/10.1074/jbc.M008107200
Li X, Qian X, Jiang H, Xia Y, Zheng Y, Li J et al (2018) Nuclear PGK1 alleviates ADP-dependent inhibition of CDC7 to promote DNA replication. Mol Cell 72(4):650–660. https://doi.org/10.1016/j.molcel.2018.09.007
Halicka HD, Huang X, Traganos F, King MA, Dai W, Darzynkiewicz Z (2005) Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis. Cell Cycle 4(2):339–345
Acknowledgements
We thank Drs. Olaf-Georg Issinger and Stephen Douthwaite for helpful discussion, Dr. Mohammad Aarif Siddiqui for technical assistance with the IncuCyte measurements and Agnieszka Weronika Adamczyk for preliminary results.
Funding
This work was supported with funding from the Novo Nordisk Foundation (Grant nr.: NNF17OC0028720) to B. Guerra.
Author information
Authors and Affiliations
Contributions
B.G. designed the project, carried out a large part of the experiments, wrote part of the manuscript and provided financial support. T.K.D. performed the bioinformatics analysis and wrote part of the manuscript. S.B.F. contributed to results shown in Figs. 1, 2 and 7 and RNA-seq. data generation. K.S. participated in data analysis and critical discussion of the study. B.S.A. contributed to data analysis, critical discussion of the study and the drafting of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
18_2022_4374_MOESM1_ESM.tiff
Supplementary file1 Suppl. Fig S1. Expression pattern of phosphorylated CHK1 and H2AX in cells - negative controls. A Negative control (NC) for phospho-CHK1 (S345) staining of myoblasts cells. Images were taken at 20x magnification. Scale bar represents 50 μm. B Negative control for phospho-H2AX (S139) staining of myoblasts cells. Images were taken at 40x magnification. Scale bar represents 20 μm (TIFF 851 KB)
18_2022_4374_MOESM2_ESM.tiff
Supplementary file2 Suppl. Fig S2. Response of myoblasts to treatment with aphidicolin or exposure to UV irradiation. A, C Cells were treated with 5 μM aphidicolin (Aph) to inhibit DNA polymerase (A) or exposed to 60 J/m2 UV irradiation (C) to induce DNA replication stress [49]. Cells were harvested at different time points and analysed by Flow cytometry after staining the DNA with propidium iodide. *P < 0.005 with respect to control cells at 24 h, and 36 h, respectively (A), *P = 0.05 with respect to control cells at 12 h and #P < 0.005 with respect to control cells at 24 h (C). B, D Western blot analysis of whole lysates from cells treated essentially as indicated above, was carried out employing antibodies against proteins indicated in the figure. β-actin detection served as loading control. (TIFF 3334 KB)
18_2022_4374_MOESM3_ESM.tiff
Supplementary file3 Suppl. Fig S3. Gene expression changes within the cell cycle pathway following treatment of H9c2-CK2α-44 with Dox, HU, or a combination. Following treatment of cells with either 1 μg/ml Dox for 72 h, 3 mM HU for 24 h or a combination, RNA-sequencing was used to obtain log2 fold-change estimates of gene expression changes relative to untreated controls. The changes in gene expression are indicated in colour, with bright red indicating a positive log2 fold-change of at least 2, and bright blue a negative log2 fold-change of at least 2. The three conditions are displayed such that for each gene or gene-group, the first colour shows the change in gene expression following Dox treatment alone, the second colour the combination of Dox and HU, and the last colour the effect on gene expression following treatment with HU alone.(TIFF 1247 KB)
18_2022_4374_MOESM4_ESM.tiff
Supplementary file4 Suppl. Fig S4. Gene expression changes relative to proteins previously examined by Western blot. Cells were treated as indicated in Suppl. Fig S3. RNA-sequencing was used to obtain normalized expression estimates of genes coding for proteins examined by Western blot. The four different conditions are indicated by colour as indicated in the figure. Gene expression estimates were log10 transformed to plot highly differing gene expression estimates within the same plot.(TIFF 1344 KB)
18_2022_4374_MOESM5_ESM.tiff
Supplementary file5 Suppl. Fig S5. Analysis of complex formations in U2OS cells following down-regulation of CK2α and DNA replication stress induction. A U2OS cells were treated with 3 mM HU and harvested at the indicated time points. *P < 0.005 with respect to control cells at 6 h, 12 h, and 24 h, respectively. Experiments were subsequently carried out as described in Fig 1A. B, C Cells were transfected for 56 h with CK2α-siRNA to induce down-regulation of the protein kinase. It followed incubation with 3 mM HU for additional 4 h before harvesting. Whole cell lysates were subsequently subjected to immunoprecipitation assays essentially as described in Fig 5 with anti-CDC45 (B) and anti-CLSPN antibodies (C), respectively. D Whole cell lysate from U2OS cells was employed in immunoprecipitation studies as described in Fig 5H. The identification of the co-precipitated proteins was carried out by Western blot employing antibodies indicated in the figure. In the analysis of the immunoblots, we noticed that the detection of MCM7 resulted in two band signals corresponding to proteins with distinct molecular weights suggesting co-immunoprecipitation of full length and a shorter form of MCM7. This is plausible as alternatively spliced transcript variants encoding distinct isoforms of MCM7 have been reported (http://atlasgeneticsoncology.org/Genes/GC_MCM7.html). (TIFF 1939 KB)
18_2022_4374_MOESM6_ESM.tiff
Supplementary file6 Suppl. Fig S6. Analysis of cells by quantitative image-based cytometry (QIBC) reveals decreased levels of phosphorylation of H2AX in cells with down-regulation of CK2α and exposed to HU. A QIBC analysis of cells exposed to 3 mM HU for the indicated times and immunostained for γ-H2AX. Nuclear DNA was counterstained by 4′,6-diamidino-2-phenylindole (DAPI), n >4,000 cells for each condition. The colour gradient indicates the mean nuclear γ-H2AX intensity. A.U., arbitrary units. B Quantification of γ-H2AX signal intensity from the experiment performed in A. The data points represent average values. n > 4,000 cells. Statistical analysis were done with GraphPad Prism (GraphPad Software version 9) using one-way ANOVA. (TIFF 8428 KB)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Guerra, B., Doktor, T.K., Frederiksen, S.B. et al. Essential role of CK2α for the interaction and stability of replication fork factors during DNA synthesis and activation of the S-phase checkpoint. Cell. Mol. Life Sci. 79, 339 (2022). https://doi.org/10.1007/s00018-022-04374-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-022-04374-3